I agree that this site is using cookies. You can find further informations here.
X
Dilzer, Stacy C
21  results:
Search for persons X
?
1

Evaluation of the Single-dose Pharmacokinetics of Bilastine..:

Lasseter, Kenneth C. ; Sologuren, Ander ; La Noce, Anna.
Clinical Drug Investigation.  33 (2013)  9 - p. 665-673 , 2013
Link: https://doi.org/10.1007/..
 
?
2

Intravenous conivaptan: Effects on the QTc interval and oth..:

Lasseter, Kenneth C. ; Dilzer, Stacy C. ; Smith, Neila
Advances in Therapy.  24 (2007)  2 - p. 310-318 , 2007
Link: https://doi.org/10.1007/..
 
?
3

Pharmacokinetics of Long‐Acting Naltrexone in Subjects With..:

Turncliff, Ryan Z. ; Dunbar, Joi L. ; Dong, Qunming...
The Journal of Clinical Pharmacology.  45 (2005)  11 - p. 1259-1267 , 2005
Link: https://doi.org/10.1177/..
 
?
4

Pharmacokinetics and Safety of Ebastine in Patients with Im..:

Lasseter, Kenneth C ; Dilzer, Stacy C ; Vargas, Ramon..
Clinical Pharmacokinetics.  43 (2004)  2 - p. 121-129 , 2004
Link: https://doi.org/10.2165/..
 
?
5

Pharmacokinetics of Etoricoxib in Patients with Hepatic Imp..:

Agrawal, Nancy G. B. ; Rose, Mark J. ; Matthews, Catherine Z....
The Journal of Clinical Pharmacology.  43 (2003)  10 - p. 1136-1148 , 2003
Link: https://doi.org/10.1177/..
 
?
6

Influence of hepatic impairment on everolimus pharmacokinet..:

Kovarik, John M. ; Sabia, Helene D. ; Figueiredo, Joaquim...
Clinical Pharmacology & Therapeutics.  70 (2001)  5 - p. 425-430 , 2001
Link: https://doi.org/10.1016/..
 
?
7

Pharmacokinetics and Pharmacodynamics of Zolmitriptan in Pa..:

Smith, Deborah A. ; Cleary, Elena W. ; Watkins, Stephanie...
The Journal of Clinical Pharmacology.  38 (1998)  8 - p. 685-693 , 1998
Link: https://doi.org/10.1002/..
 
?
8

Evaluation of the Single-dose Pharmacokinetics of Bilastine..:

Lasseter, Kenneth C ; Sologuren, Ander ; La Noce, Anna.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751212.  , 2013
Link: http://www.ncbi.nlm.nih...
 
?
9

Potential for Interactions between Caspofungin and Nelfinav..:

Stone, Julie A ; Migoya, Elizabeth M ; Hickey, Lisa...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC525392.  , 2004
Link: http://www.ncbi.nlm.nih...
 
?
10

Disposition of Caspofungin: Role of Distribution in Determi..:

Stone, Julie A ; Xu, Xin ; Winchell, Gregory A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC353127.  , 2004
Link: http://www.ncbi.nlm.nih...
 
?
11

Single‐ and Multiple‐Dose Administration of Caspofungin in ..:

Mistry, Goutam C. ; Migoya, Elizabeth ; Deutsch, Paul J....
The Journal of Clinical Pharmacology.  47 (2007)  8 - p. 951-961 , 2007
Link: https://doi.org/10.1177/..
 
?
12

Dose‐proportionality of a final market image sitagliptin fo..:

Bergman, Arthur ; Mistry, Goutam C. ; Luo, Wen‐Lin...
Biopharmaceutics & Drug Disposition.  28 (2007)  6 - p. 307-313 , 2007
Link: https://doi.org/10.1002/..
 
?
13

Interactions between Simvastatin and Troglitazone or Piogli..:

Prueksaritanont, Thomayant ; Vega, José M. ; Zhao, Jamie...
The Journal of Clinical Pharmacology.  41 (2001)  5 - p. 573-581 , 2001
Link: https://doi.org/10.1177/..
 
?
14

The influence of hepatic impairment on the pharmacokinetics..:

He, Y.-L. ; Sabo, R. ; Campestrini, J....
European Journal of Clinical Pharmacology.  63 (2007)  7 - p. 677-686 , 2007
Link: https://doi.org/10.1007/..
 
?
15

Pharmacokinetics of Sirolimus (Rapamycin) in Subjects With ..:

Zimmerman, James J. ; Lasseter, Kenneth C. ; Lim, Heng‐Keang...
The Journal of Clinical Pharmacology.  45 (2005)  12 - p. 1368-1372 , 2005
Link: https://doi.org/10.1177/..
 
1-15